Pritesh Shah currently serves as Novocure’s Chief Growth Officer, where he oversees global product and portfolio strategy, brand management, market access and market intelligence. Mr. Shah joined Novocure in November 2012 and most recently held the title of Chief Commercial Officer. Prior to joining Novocure, Mr. Shah had extensive experiences in leading oncology commercial and medical affairs functions at Roche, Genentech, Bristol-Myers Squibb, OSI Oncology and AVEO Oncology. He holds a Doctor of Pharmacy from the University of Maryland and a master’s degree in Strategic Communication and Leadership from Seton Hall University.